Opinion
-
One in Three Have it
Opinion -Arthritis affects one in three adults in the United States. The fact that our population is increasingly overweight, inactive, and aging is contributing to the rapid increase in arthritis. -
President Signs ‘Budget-Busting’ Medicare Reform
Opinion -After months of Congressional debate, President George W. Bush on December 8 signed a Medicare reform measure expected to increase spending on the program by $400 billion over the next 10 years. -
Rx Discount Card
Opinion -Seniors and the disabled enrolled in the Medicare Drug Discount Card Program should save about 17.4 percent on average. This is according to new research from Harvard University. -
Santorum Fair Care Measure Awaits Action
Opinion -With attention focused on Medicare reform and prescription drug benefits for seniors and the disabled, legislation that would directly benefit the nation’s uninsured was left unaddressed before the year-end break. -
Senior Moments
Opinion -Some mistakes involving health care are unique to senior citizens. Here are five errors seniors make in caring for themselves, recently discovered by the Institute for Healthcare Advancement from an interview with 500 seniors. 1. -
What’s in Your Medicine Cabinet?
Opinion -The foreign prescription drugs in your medicine cabinet may not be safe. -
Mad-Cow Health Hysteria
Opinion -Investigators have tentatively traced the first U.S. case of mad-cow disease to Canada, but officials there say the link is premature. -
National Symposium on Drug Importation: Small Gains, Enormous Risks
Opinion -The focus on finding ways to reduce spending on prescription drugs has turned attention away from some important facts. One fact is that spending on drugs is actually a very good investment. -
National Symposium on Drug Importation: Costs, Compulsory Licensing, and Counterfeiting
Opinion -I agree with several points Senator Lauzen made earlier. People are angry about this issue, and they really do see it as an issue of costs. But prescription drug prices are the tip of the iceberg in overall health spending. -
National Symposium on Drug Importation: Appendix 2: Letter from the FDA to the State of Illinois
Opinion -November 6, 2003 Ram Kamath Scott McKibbon Special Advocates for Prescription Drugs 100 W. Randolph Street, Floor 4, Suite 457 Chicago, Illinois 60601 Dear Dr. Kamath and Mr. -
National Symposium on Drug Importation: Introduction
Opinion -The National Symposium on Drug Importation took place in Chicago on October 23, 2003. Eight speakers from Canada and the United States presented every side of the debate over the course of a half-day program. -
National Symposium on Drug Importation: Appendix 1: Blagojevich’s $91 Million Mistake
Opinion -In October 2003, Governor Rod Blagojevich and Congressman Rahm Emanuel announced the release of a government report claiming the State of Illinois could save $91 million a year by importing Canadian drugs for state employees and retirees. -
National Symposium on Drug Importation: Don’t Just Stand There, Do Something!
Opinion -As I came in this morning, I was warned that I was the only speaker on the program with the other point of view. So it’s not the most comfortable place to be. I certainly respect every panelist who spoke today. -
National Symposium on Drug Importation: It’s Really About Spending, Not Safety
Opinion -The U.S. Chamber of Commerce is opposed to drug importation. However, I understand the position Governor Blagojevich is in. -
National Symposium on Drug Importation: Not a Solution to State Budget Problems
Opinion -Everybody relax a minute. It’s just a state senator up here. This is not a policy expert! I’m very, very interested in being here and happy to be able to participate, but somewhat reluctant to go first. -
National Symposium on Drug Importation: The Dubious Economics of Drug Importation
Opinion -It’s a pleasure to be back in Chicago. I got my training down the coast a couple of miles at the University of Chicago. I feel like I’m bringing coals to Newcastle. -
National Symposium on Drug Importation: The Pros and Cons of Drug Importation
Opinion -The speakers at this conference gave us a good idea of the depth of this issue. It is not simple. Over the course of the day, I heard seven good reasons why we should import drugs from Canada, and eight good reasons why we should not. -
National Symposium on Drug Importation: A Canadian Economist’s Perspective
Opinion -It’s a pleasure and privilege to be here. I’ve done a lot of speaking in the U.S. on this issue because it’s an issue of such concern. I hope I can keep everyone’s attention. -
National Symposium on Drug Importation: The Danger of Unknown and Unknowable Costs
Opinion -The points that are going to be made today about the safety and economics of drug importation as they relate to pharmaceutical issues and products are even more applicable to biologics: vaccines, therapeutic serums, and other biological products used -
Drug Importation Roulette
Opinion -A growing number of governors say they intend to defy federal regulators and purchase lower-cost prescription drugs from Canada. -
Rx Drug Card Appeals to Congress
Opinion -Congressional conference committee negotiators working to hammer out a Medicare reform bill have agreed a discount prescription drug card may be the only way to get a drug benefit into the hands of seniors by the end of the year. -
Insurers Wrap Up Medicare Reform Ad Campaign
Opinion -The National Association of Health Underwriters (NAHU), in partnership with the Alliance to Improve Medicare (AIM), has just completed a national advertising campaign urging Congress to pass comprehensive Medicare reform legislation with a prescription -
Patient Patients
Opinion -Canadian drug prices are the envy of politicians like Illinois Gov. Rod Blagojevich, who hopes to save a little money on his state’s Medicaid and employee health programs by importing cheaper drugs from Canada. -
Millions Already Benefit from Private Rx Discount Programs
Opinion -Medicare-eligible senior citizens and disabled Americans without prescription drug coverage need not wait for Congress to act on a drug benefit.
